Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Another Denosumab Deal For mAbxience In MEA
MS Pharma Is Set To Register And Market The Prolia/Xgeva Biosimilar In MEA Markets
15 Nov 2023
•
By
Dave Wallace
MS Pharma will market mAbxience’s denosumab in MEA territories • Source: Shutterstock
More from Deals
More from Business